Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2008;117:1750-1767
Published online before print March 10, 2008, doi: 10.1161/CIRCULATIONAHA.107.188525
Free Article
This Article
Free upon publication Free Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
117/13/1750    most recent
CIRCULATIONAHA.107.188525v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rosengart, T. K.
Right arrow Articles by O’Neill, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rosengart, T. K.
Right arrow Articles by O’Neill, W.
Related Collections
Right arrow Valvular heart disease
Right arrow AHA Statements and Guidelines
Right arrow Catheter-based coronary and valvular interventions: other
Right arrow CV surgery: valvular disease

(Circulation. 2008;117:1750-1767.)
© 2008 American Heart Association, Inc.


AHA Scientific Statement

Percutaneous and Minimally Invasive Valve Procedures

A Scientific Statement From the American Heart Association Council on Cardiovascular Surgery and Anesthesia, Council on Clinical Cardiology, Functional Genomics and Translational Biology Interdisciplinary Working Group, and Quality of Care and Outcomes Research Interdisciplinary Working Group

Todd K. Rosengart, MD, FAHA, Chair; Ted Feldman, MD; Michael A. Borger, MD, PhD; Thomas A. Vassiliades, Jr, MD; A. Marc Gillinov, MD, FAHA; Katherine J. Hoercher, RN; Alec Vahanian, MD; Robert O. Bonow, MD, FAHA; William O’Neill, MD, FAHA

The incidence of valvular heart disease is expected to increase over the next several decades as a large proportion of the US demographic advances into the later decades of life. At the same time, the next several years can be anticipated to bring a broad transition of surgical therapy to minimally invasive (minithoracotomy and small port) access and the more gradual introduction of percutaneous approaches for the correction of valvular heart disease. Broad acceptance of these technologies will require careful and sometimes perplexing comparisons of the outcomes of these new technologies with existing standards of care. The validation of percutaneous techniques, in particular, will require the collaboration of cardiologists and cardiac surgeons in centers with excellent surgical and catheter experience and a commitment to trial participation. For the near term, percutaneous techniques will likely remain investigational and will be limited in use to patients considered to be high risk or to inoperable surgical candidates. Although current-generation devices and techniques require significant modification before widespread clinical use can be adopted, it must be expected that less invasive and even percutaneous valve therapies will likely have a major impact on the management of patients with valvular heart disease over the next several years.


Key Words: AHA Scientific Statements • cardiac surgery • catheters • interventional radiology • surgery • valves • valvuloplasty




This article has been cited by other articles:


Home page
Br J AnaesthHome page
A. A. Klein, S. T. Webb, S. Tsui, C. Sudarshan, L. Shapiro, and C. Densem
Transcatheter aortic valve insertion: anaesthetic implications of emerging new technology
Br. J. Anaesth., December 1, 2009; 103(6): 792 - 799.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
E. Manasse
Cooks and recipes
Eur. J. Cardiothorac. Surg., November 1, 2009; 36(5): 787 - 790.
[Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
S. Bleiziffer, H. Ruge, D. Mazzitelli, A. Hutter, A. Opitz, R. Bauernschmitt, and R. Lange
Survival after transapical and transfemoral aortic valve implantation: Talking about two different patient populations
J. Thorac. Cardiovasc. Surg., November 1, 2009; 138(5): 1073 - 1080.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
L. F Tops, V. Delgado, F. van der Kley, and J. J Bax
Percutaneous aortic valve therapy: clinical experience and the role of multi-modality imaging
Heart, September 15, 2009; 95(18): 1538 - 1546.
[Full Text] [PDF]


Home page
Circ Cardiovasc Qual OutcomesHome page
T. Grebel and J. Schumm
Job Matters: Differences in Risk Assessment of Percutaneous Aortic Valve Replacement Between Cardiologists and Cardiac Surgeons
Circ Cardiovasc Qual Outcomes, September 1, 2009; 2(5): 465 - 468.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
G. P. Ussia, M. Mule, M. Barbanti, V. Cammalleri, M. Scarabelli, S. Imme, D. Capodanno, S. Ciriminna, and C. Tamburino
Quality of life assessment after percutaneous aortic valve implantation
Eur. Heart J., July 2, 2009; 30(14): 1790 - 1796.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
S. Bleiziffer, H. Ruge, D. Mazzitelli, C. Schreiber, A. Hutter, J.-C. Laborde, R. Bauernschmitt, and R. Lange
Results of percutaneous and transapical transcatheter aortic valve implantation performed by a surgical team
Eur. J. Cardiothorac. Surg., April 1, 2009; 35(4): 615 - 621.
[Abstract] [Full Text] [PDF]


Home page
Heart AsiaHome page
R Goel, P P Sengupta, F Mookadam, H P Chaliki, B K Khandheria, and A J Tajik
Valvular regurgitation and stenosis: when is surgery required?
Heart Asia, March 31, 2009; 2009(3): 5 - 10.
[Abstract] [Full Text] [PDF]


Home page
ESC Textbook of Cardiovascular MedicineHome page
A. Vahanian, B. Iung, L. Piérard, R. Dion, and J. Pepper
CHAPTER 21 Valvular Heart Disease
ESC Textbook of Cardiovascular Medicine, January 1, 2009; 2(1): med-9780199566990-chapter - med-9780199566990-chapter.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
A. Zierer, G. Wimmer-Greinecker, S. Martens, A. Moritz, and M. Doss
The transapical approach for aortic valve implantation.
J. Thorac. Cardiovasc. Surg., October 1, 2008; 136(4): 948 - 953.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. S. Gammie, L. S. Krowsoski, J. M. Brown, P. N. Odonkor, C. A. Young, M. J. Santos, J. S. Gottdiener, and B. P. Griffith
Aortic Valve Bypass Surgery: Midterm Clinical Outcomes in a High-Risk Aortic Stenosis Population
Circulation, September 30, 2008; 118(14): 1460 - 1466.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
A. Vahanian, O. Alfieri, N. Al-Attar, M. Antunes, J. Bax, B. Cormier, A. Cribier, P. De Jaegere, G. Fournial, A. P. Kappetein, et al.
Transcatheter valve implantation for patients with aortic stenosis: a position statement from the European Association of Cardio-Thoracic Surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of Percutaneous Cardiovascular Interventions (EAPCI)
Eur. Heart J., June 1, 2008; 29(11): 1463 - 1470.
[Abstract] [Full Text] [PDF]